Posts by Ik-Kyung Jang, MD, PhD
Viewpoint: New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes
Plaque erosion deserves more attention as a distinct entity in patients with acute coronary syndromes—notably because it may potentially be managed with antithrombotic therapy alone without stenting, according to Dhaval Kolte, MD, PhD, and Ik-Kyung Jang, MD, PhD, of the Cardiology Division, and a colleague.
STEMI Due to Plaque Rupture Most Likely to Occur in Morning
Acute myocardial infarction caused by plaque rupture may be related to catecholamine surge in the morning.
Healed Plaques Signal Vulnerability to Future Acute Coronary Syndrome
Based on the first in vivo study of healed plaques in patients who have had acute coronary syndrome (ACS), cardiologists at Massachusetts General Hospital warn that these plaques frequently show features of vulnerability to future major cardiac events.
3-D Analysis of Fibrous Caps Suggests Need to Rethink Atherosclerotic Plaque Vulnerability
Following computer-assisted, 3-D volumetric analysis of atherosclerotic plaque, cardiologists at Massachusetts General Hospital have new ideas about which patients may be vulnerable to acute coronary syndromes.
Coronary Artery Disease - Reporting & Data System (CAD-RADS)
Massachusetts General Hospital clinicians discuss a male age 55 that presents with left sided chest pain and has a history of hypertension and hyperlipidemia.
Dr. Jang came to Massachusetts General Hospital in 1987 from Leuven University in Belgium, where he has completed his residency in medicine and fellowship in cardiology. He also successfully defended his doctorate thesis at the same university. After his advanced fellowship in cardiology at MGH, he joined the staff and is currently working as a Physician and an interventional cardiologist in the Cardiology Division. He holds currently an academic title of Professor of Medicine at Harvard Medical School.
A recipient of the Partners in Excellence Award for Research in 2000 and for leadership in 2006, his research roster is extensive, and is focused on acute coronary syndromes including acute myocardial infarction. His earlier research focused on pharmacology and physiology of thrombosis and thrombolysis. In 1994 he extended his interests to clinical studies. Since founding the Coronary Clinical Trial Group within the Cardiac Unit in 1995, he has conducted numerous clinical studies. He also led Clinical Research Office of the Cardiology Division between 2003 and 2006. He is currently the Director of the Cardiology Laboratory for Integrative Physiology and Imaging (CLIPI).